Tom Kukla is responsible for a team of Directors and Coordinators whose purpose is to Coach, Lead, Train, Develop, and Grow District Sales Managers at Purdue Pharma. Their overall Mission is to bring value to the District Sales Managers, improving their Leadership and Management skills in order to make them more effective, and their results speak for themselves. The team, over the last 18 months, was responsible for the launch of two major corporate initiatives; the Challenger Sale (a new sales model); and E2E (a new territory management protocol). Their Field Coaches are highly sought after for their sales expertise and are typical on a short list of soon to be promoted Sales Leaders. At Purdue, Tom’s top priority over the next 12 months is to lead the Sales Managers in the implementation of two key initiatives: The Challenger Sale model; and E2E.

Dave has spent over 15 years developing and managing pharmaceutical commercial programs, with the majority of those years spent with the Ortho-McNeil and Janssen Pharmaceutical divisions within Johnson & Johnson. Mr. Moore has held leadership roles in key sales and marketing functions, and was part of teams that developed and executed launch plans for several prescription pharmaceuticals for both primary and acute care settings. He developed payer value platforms for several therapeutic areas including antibiotics, pain and women’s health, in which he successfully implemented pricing and reimbursement strategies with hospitals and managed care organizations. Following Johnson & Johnson, he was chief business officer and vice president of Worldwide Commercial Operations of Tranzyme, Inc., where he was responsible for building the commercial organization as well as in- and out-licensing clinical-stage assets and was chief business officer of Ocera Therapeutics where he was responsible for developing the commercial plans for an Orphan-designated advanced liver disease product for both the community and acute care markets. Mr. Moore received his B.Sc. in Biology from Towson University and an M.B.A. from Lehigh University, and a second graduate degree in Health Policy Excellence from Thomas Jefferson University and is currently part-time faculty at Duke Fuqua business school.

Mike leads a sales team comprised of Primary Care Sales Representatives, Specialty Sales Representatives, District Sales Managers, Regional Directors, Field Business Managers and a co-promote relationship selling Pharmaceutical products in the Metabolic/Cardiovascular/Urology and Diabetes markets. We are experiencing unprecedented change and challenge within the pharmaceutical industry where it seems “Compliance Adherence” is becoming the new “Blockbuster product”. By using compliance as a competitive advantage a pharmaceutical company can retain $billions of dollars in fines levied by governmental organizations. So it is in our industries best interest to strategize accordingly!

Mike's current goal is to lead selling efforts in an ever changing environment riddled with challenge (Health Care Reform/ Strict Compliance adherence focused efforts) all the while finding ways to inspire and motivate our selling teams to provide discretionary effort every day!  GSK is truly an organization who champions our corporate vision here in the US, “Helping Patients Do More, Feel Better and Live Longer”  It is not just a catchy tag line but rather a verbal reminder before and after every meeting we have, every strategy we build and execute…if it doesn’t help us accomplish this Vision…we simply won’t do it!

In her current role, Jennifer is responsible for developing curriculum on the Evolving Health Care Market that has specific impact on our customers, from their point of view.  Her goal for 2014 is to develop and deliver this curriculum to the field facing colleagues, create and deliver tools to help with comprehension and taking the learning from education to application.  This is a cross-functional effort with sales, marketing, account management, HR, training and legal (just to name a few).  The goal is to increase relevance of our field-facing colleagues in the eyes of customers, to better understand how their business has changed, and how products / resources may be appropriately leveraged.

With a digital background that spans more than 25 years and over 10 years as a digital marketer in Pharma, Deb Nevins is a uniquely qualified Digital Strategist. Currently supporting BI as an Associate Director of Digital Promotion and MCM Strategy she is responsible for creating brand experiences that not only address the customer need but also satisfy the brand marketing goals. Deb is part of the team currently leading the organization through the implementation of a true Multichannel marketing customer engagement strategy. Bi recognizes the need to understand what our customers need from a marketing prospective and has taken a leadership role in developing the right mix of content and channels to address those needs.

Rodney Somerville has over 20 years of business and industry experience.  He is widely recognized for his cross-functional business and project leadership with experience in Management Development, Sales Training, Procurement, District Management, Marketing, Sales, and Six Sigma consulting.

As a Senior Manager for Management Development at Johnson and Johnson, Rodney is responsible for development, execution, and measurement of Management Development training initiatives across Janssen and the key contact for the Janssen Biotech Organization.

Carol is responsible for all Sales Training and Operations for a start up company including 30 representatives and a field management team of 4.  Since starting with the organization in January of 2013, she has had several initiatives including the development, implementation and facilitation of all training materials for the company launch meeting, all logistics and planning for the meeting as well as all appropriate vendor selection, SOP and business rule development for the operations side of the department. 

The company successfully launched in August of 2013 and they continue to develop ongoing training and vendor relationships to enhance sales and territory management.  Maximizing Sales While Minimizing Risk is a suitable topic for Carol having spent 12 plus years in training and in operations, including compliance.   In the current regulatory environment, including transparency and off label promotions guidelines it is more important than ever that representatives stay with in compliance. 

Brian is responsible for both corporate and product marketing at Medac Pharma. They are in the midst of launching the company in the US and are prepping for the launch of our first product in the second half of 2014. They've just started on the corporate awareness campaign, with a mix of traditional print and digital initiatives. Their goal is to build awareness of the company in preparation for the launch of the product.

Matt is currently the Team Lead for Commercial Effectiveness for the Pfizer. He and his team are responsible for evolving the Primary Care Business Model to meet the rapidly evolving needs of Health Care Providers and Organizations in the US. Prior to his current role Matt served as Vice President, Managed Markets for Pfizer. Previous experience included a number of positions in Sales Leadership, Account Management Leadership, Marketing Leadership and Operations with Pfizer, Pharmacia and Bristol-Myers Squibb.

Paige Querol, M.S.Ed., Ed.D., is an experienced Learning and Development Professional responsible for providing  specialized training services to a variety of pharmaceutical and biotech companies.  She has designed, written and managed development of a wide range of educational curricula, including workshops, self-study text, classroom curriculum, case studies and technology-based material.  With 22 years in the pharmaceutical industry, Paige has held a number of different roles within the commercial space including Sales, Sales Operations, Conference Services and Sales Training positions and has significant experience implementing selling models, building training infrastructures for newly-commercialized companies, launching learning management systems, building leadership programs and supporting new product launches.  She has been very interested in helping sales colleagues become more successful in the field by utilizing a newer learning approach called confidence based learning. and believes that it's a critical skill to master in order for corporations to reach their overall business goals.  She earned her Bachelors degrees in Biology, Chemistry and Psychology from Syracuse University, and holds a Masters of Science in Education and a Doctorate in Education from the University of Pennsylvania, where she focused on Work-Based Learning Leadership and Chief Learning Officer curriculum.

Abel Rajan is Director of Marketing Analytics & Insights at Novartis. In this role, he leads a team that assesses marketing impact, and optimizes the mix of promotional efforts (both sales & marketing) across a number of in-line and launch brands at Novartis. Further, he is responsible for planning, and enhancing capabilities that connect with customers across newer promotion channels. Since joining Novartis, Abel’s team has successfully set up capabilities to learn new channel effectiveness, transforming customer interactions through digital platforms, and exploring promotion partnerships in the changing health landscape.

Prior to joining the pharmaceutical industry, Abel worked at agencies such as Epsilon and McCann Worldgroup where he created holistic marketing plans across numerous brands within the pharmaceutical, retail, financial services, and consumer packaged goods industry . His work focused mostly on direct marketing, market research, planning and marketing effectiveness. Prior to this marketing agency experience, Abel worked at marketRx where he specialized in sales force optimization and planning for various pharmaceutical companies.

Abel received his undergraduate degree from Indian Institute of Technology (IIT) and has an MS from Penn State University

In his 20+ years in the Biotech/Pharmaceutical industry, Joe Renda has gained broad & deep experiences across commercial operations. He has over a decade of top performance in sales management and leadership positions, enhanced by years’ of experience developing and training District Business Managers, and has implemented numerous regional, national & corporate Sales & Business Operational best practices. Additionally, he is considered an accomplished Marketing leader having created & executed an innovative launch approach that resulted in the brand being a market leader in women’s health. Currently, Joe is responsible for North America Commercial Operations & Effectiveness for Novo Nordisk’s Biopharmaceutical division which includes Sales Operations, Market Research, Sales Analytics, Brand & Sales Planning, and Incentive Compensation.

He completed his undergraduate work at The Pennsylvania State University with a degree in Accounting and he has continued his formal Business & Leadership development through executive programs at Wharton & Harvard. He is an accomplished pharmaceutical leadership columnist who has compiled a series of articles designed at helping industry leaders drive results through strategy, coaching, and development of their team members.

Bob Rossilli is currently the Vice President  & Head of Diabetes Sales for Sanofi US.

With over 20 years of experience in the pharmaceutical industry Bob has continually demonstrated a passion for building customer focused teams. In his current role, Bob leads sales teams across a number of different channels including primary care, specialty, pharmacy, Hospitals, IDNs / ACOs and long term care.  He works closely with a variety of external customer groups and internal stakeholders to ensure leading-edge diabetes therapies and patient-centric solutions are helping improve outcomes in local communities across the US.

Charlotte has built and led integrated MR, CI, Commercial Assessment, Strategic Forecasting and Decision Science departments in 6 major companies, including big pharma, biotech and specialty pharma. She knows the power of insights,  data and analytics and have been fired for "telling truth to power" and saying "your baby is ugly". We can no longer afford to ignore these powerful insights and what our customers want and need.  This is a big part of why the industry is more part of the problem rather than part of the solution. If we do not start thinking of customers more broadly and responding to their real needs, rather than what we think they need, we will be marginalized and become mostly a commodity business.

Cecil has spent his career in sales, management and learning & development.  He is currently Director, Management Development for the North America Pharmaceutical Companies of Johnson & Johnson (Janssen). 

Under his direction, his team has developed a new Management Development Curriculum for emerging people leaders, new and tenured District Managers and Business Directors.  An example of his vision and creativity are innovative programs such as: the Janssen Business Challenge, a cross-organization, project-based, action-learning program for high performing Region Business Directors.  The outcome is a solution to a current, urgent, organization-wide business problem; as well as a competency stretching experience for top talent.

Linda is passionate about helping businesses build smart, contemporary brand strategies and marketing programs. She’s been lucky enough to spend the last decade leading successful launches for brands that make the world a bit healthier – as a Global Marketing Director for GSK Consumer Healthcare, and before that as agency lead for the Toyota Prius US launch.   Linda's consultancy helps brands find their DNA, create programs that build lasting relationships with key audiences, and thrive in the digital world. Linda has studied behavior change design with Stanford’s BJ Fogg, is a member of the Healthcare Women’s Business Association, a two time global Effie's judge, and trained in “Just in Times Manufacturing “ by Toyota.

M.J. Anderson is Chief Marketing Officer and a founding partner of Trekk, a multi-channel marketing agency. He meshes his background in traditional design and conceptual development with more than 25 years of experience working in new media and integrated marketing communications. Always on the lookout for new tools and technologies, he leads the Trekk team in the formation of innovative and effective communication strategies and tactics for some of today’s most recognizable brands.
M.J. is a frequent speaker at industry conferences and events where he shares his expertise on increasing marketing relevance through tools such as mobile apps, video, social media and augmented reality.

Jeff is responsible for introducing Qstream solutions into some of the world's largest and most progressive enterprises. His experience building and leading high-performance sales organizations at start up and Fortune 100 companies includes more than two decades of senior leadership roles at IBM and Digital Equipment Corporation (now HP). Jeff's entrepreneurial energy and domain expertise in technology, analytics and eLearning has made him a trusted advisor to executives in life sciences, high tech and financial industries.

He has a BS in Finance from the University of Illinois and an MBA from the Kellogg School at Northwestern. When not racing to his next client meeting, Jeff is passionate about cars.

Bill Coyle is a Principal with ZS Associates, based in the firm’s Princeton office. He leads ZS’s team focused on Key Account Management in pharma and biotech, leveraging his expertise in commercial organization design and market access. Bill's work at ZS has spanned many key areas of sales and marketing in the pharma and biotech industries. His areas of expertise include sales operations and analytics, commercial organization design and optimization, and market access and pricing / managed care.

In addition to his experience in the U.S., Bill helped found ZS’s Zurich office, where he worked with industry global and regional Europe HQs. His experience prior to joining ZS includes industrial sales and marketing in the plastics industry.

Bill holds a Bachelor of Science in Chemical Engineering from the University of Maryland and an M.B.A. from the Kellogg School of Management at Northwestern University,

Peter brings 21 years experience in the pharmaceutical industry serving in a variety of sales, product development, and analytic services roles with top pharmaceutical companies and professional services firms.  In his current role within Quintiles commercial operations, Peter directs integrated channel management services as well as strategic analytics projects.

Before joining Quintiles in 2004, Peter was employed at Analytika Inc. as Director of Analytical Services, where he led the design and development of analytic products & services as well as consulting projects leveraging a proprietary longitudinal patient database.  He has conducted a variety of analyses in the drug safety arena, including projects with FDA Office of Drug Safety.

With over 20 years of diverse experience in both commercial and medical assignments, spanning both domestic and international markets, Robert brings a skill set and perspective that is rare among pharmaceutical professionals. 
His experience has enabled him to develop a deep understanding of opinion leadership, medical education, and communications, with a specific emphasis focused on achieving complex medical and commercial therapeutic and strategic objectives. 
With a clear understanding of drug development and commercialization processes, Robert has been able to develop plans and coordinated initiatives that optimize strategic stakeholder engagement and Opinion Leader opportunities to consistently achieve marketplace success. Colleagues and clients describe Robert as innovative, outgoing, creative, focused, smart, and passionate. He brings an uncompromising level of dedication to the quality of his work and an absolute commitment to achieving the highest results for his clients.

Andy Jacobson is currently the VP Sales for Epsilon’s Digital organization. He is tasked with the hiring, training and scaling of the sales organization.

Prior to joining Epsilon, Andy was the VP of Sales for Everyday Health. He led the premium content sales team and also launched a data product leveraging 1st party health data; building the sales organization as well as helping to iterate the product.

Jacobson has worked in the digital space since 1997, beginning with his role as Sales VP running multiple media businesses at DoubleClick. During that time, he built a $100mm telesales business, launched the email media business and established an internal start up ad network called Sonar.

As VP of Sales at ValueClick Media, Jacobson helped develop both the ad network and lead generation businesses. This success led him to a role at ContextWeb, where he helped secure investor financing and transformed the start up into a $25mm business in 3 years.

Jacobson also spent a year as consultant to Google, helping them to hire and train the AdSense sales and business development teams. Prior to joining Everyday Health, Andy headed up digital sales for USA Today and all of the Gannett properties.

Jacobson has been managing online media sales organizations for the past 16 years.

Sanjay Joshi is a Managing Principal on ZS Associates' executive team and is based in the firm's New York office. Sanjay leads the firm-wide Operations and Technology Solutions area, overseeing ZS’s global offerings in operations, technology and outsourcing. Sanjay's experience spans multiple industries, including healthcare, technology, consumer products and financial services. Prior to joining ZS, Sanjay ran a number of global businesses for large public firms. He served as chief executive of Wipro Consulting and vice chairman of Wipro’s business process outsourcing division. Before Wipro, he served as chief marketing officer at Infosys Technologies. Earlier, he advised Fortune 500 companies on issues of strategy, organization, and operations at McKinsey & Company.

Sanjay holds a bachelor’s degree in computer engineering from India’s Birla Institute of Technology, an M.S. in computer science from Pennsylvania State University, and an M.B.A. from the Kellogg School of Management at Northwestern University.

Mahmood Majeed is a Principal with ZS Associates, based in the firm’s Evanston, IL office. He is a leader in ZS’s Business Intelligence practice, with particular focus on Oncology and Specialty Therapeutics. For the past 15 years, he has worked with a wide variety of clients in pharmaceuticals and biotech, delivering innovation and value to drive sales and marketing effectiveness. Mahmood has deep expertise in technology transformation across all aspects of commercial areas from strategy and vision to capability development and business process outsourcing.

Mahmood holds a Master of Information Systems degree from DePaul University, an Executive M.B.A certificate from the Kellogg School of Management at Northwestern University, and a Bachelors of Architecture degree from the University of Oklahoma.

Dr. Ryan Million is a Partner at Trinity Partners, LLC, a leading US-based strategic healthcare consulting firm, and the founder and manager of Trinity’s New York City office.  Upon joining Trinity in 2002, Dr. Million has worked with clients in new product development, business development, market analytics, and sales and marketing in several therapeutic areas including oncology, allergy and respiratory, pulmonology, ophthalmology, pain, urology, CNS, CV, diabetes and anti-infectives.  Current and past clients include top U.S, European and Japanese pharmaceutical companies and biotechnology companies.  Results delivered to Dr. Million’s clients include several successful licenses and acquisitions, entry and expansion in growth therapeutic areas and early identification of strategic drivers for in-line and pipeline products.
 
In addition, Dr. Million brings experience from engeneOS, Inc., a venture-backed biotechnology start-up company in Waltham, MA, where he was a member of the business development team.  Dr. Million completed his doctorate training in the Genetics Department at Harvard University publishing several peer-reviewed scientific papers on the ABL oncogene (target of Novartis’s Gleevec) and a mouse model of chronic myeloid leukemia.  Dr. Million attended the University of California, San Diego where he earned a B.S. in Chemistry/Biochemistry, graduating cum laude and Phi Beta Kappa.

Jasmin leads a-connect's US offices where he serves clients with a focus on health care and life sciences . His past experiences have cut across 3 continents and a spectrum of roles including head of M&A assessments and long term strategy for Novartis Pharma (Basel), COO for Novartis Pharma (Mumbai), and MD for Fidelity Growth Partners India. In the first decade of his career, Jasmin was a management consultant with McKinsey (New Jersey) and a R&D Group Leader with Chugai Biopharmaceuticals (California). He has also held a number leadership roles with industry organizations like AAPS and ACS. He has a PhD in the pharmaceutical sciences, trained at Scripps Clinic and graduated with an MBA from the Wharton School.

Ryan Roberts is the founder and CEO of Elandas – an emerging technology company that helps pharmaceutical, medical device and biotechnology sales and marketing leaders gain market share by expediting time to market.

For almost two decades, Ryan has been helping clients achieve significant breakthroughs in process efficiency, collaboration and business analytics through delivery of technology enabled business systems. For the last decade, he has been almost exclusively focused on the life sciences industry.

Ryan loves business, technology and creative problem solving. He is a visionary, and a hands-on leader among a group of independent but collaborative builders. Curiosity and vision have directed his career and his commitment to the people he works with sustains it.